"{\n    \"Title\": \"Year ended April 30, 2018 with comparative information for 20172018 2017\",\n    \"row 1\": \"Invested\",\n    \"row 2\": \"in capital\",\n    \"row 3\": \"assets Internally\",\n    \"row 4\": \"Unrestricted (note 9) restricted Endowments Total Total\",\n    \"row 5\": \"Net assets (deficiency)\",\n    \"row 6\": \"beginning of year $ (6,136,160) $ 27,429,201 \\u00a7 5,800,027 \\u00a7$ 5,376,133 $ 32,469,201 $ 29,401,389\",\n    \"row 7\": \"Excess (deficiency) of revenues over\",\n    \"row 8\": \"expenditures for the year 1,518,284 (1,120,703) - - 397 581 2,588,708\",\n    \"row 9\": \"Change in investment in\",\n    \"row 10\": \"capital assets (note 9) (1,091,912) 1,091,912 - - - -\",\n    \"row 11\": \"Endowment contributions, net\",\n    \"row 12\": \"(note 3 (a)) - - - (160,961) (160,961) (182,861)\",\n    \"row 13\": \"Net change in endowment\",\n    \"row 14\": \"investments - - - 63,201 63,201 661,965\",\n    \"row 15\": \"Transfer (note 14) 922,037 - (922,037) - - -\",\n    \"row 16\": \"Net assets (deficiency),\",\n    \"row 17\": \"end of year $ (4,787,751) $ 27,400,410 \\u00a7$ 4,877,990 \\u00a7$ 5,278,373 $ 32,769,022 $ 32,469,201\",\n    \"row 18\": \"See accompanying notes to financial statements.\"\n}"